Nutriband(NASDAQ) NTRBW

Market CapN/A

Since IPO (2021)-76%

5 YearN/A

1 Year-75%

1 Month+40%

$0.35

-22.22%

-0.10Today

Nutriband last closing stock price
Metric	Price	Date
Last close	USD 0.35	2026-09-01

Nutriband stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-30%	USD 0.50	2026-08-25
1 month	+40%	USD 0.25	2026-07-31
3 month	-61.11%	USD 0.90	2026-06-03
Year to date	-78.26%	USD 1.61	2025-12-31
1 year	-75%	USD 1.40	2025-08-29
3 year	-48.54%	USD 0.68	2023-09-01
Since inception	-75.86%	USD 1.45	2021-10-01

Nutriband Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.80M

Net Income (TTM)

-$8.08M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.35

Volume

5,500

Open

$0.44

Price

$0.35

Volume

5,500

Open

$0.44

Previous Close

$0.35

Daily Range

$0.35 - $0.45

52-Week Range

$0.25 - $2.99

Estimated Earnings Date

Sep 30, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.35

Volume

5,500

Open

$0.44

Previous Close

$0.35

Daily Range

$0.35 - $0.45

52-Week Range

$0.25 - $2.99

Estimated Earnings Date

Sep 30, 2026

NTRBW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nutriband

Nutriband Inc. is a pharmaceutical company focused on developing innovative transdermal drug delivery systems. The company is particularly known for its abuse-deterrent fentanyl transdermal system, aimed at improving chronic pain management.

Products and Services

Abuse-deterrent fentanyl transdermal system for chronic pain management
Licensing agreement with Rambam Med-Tech for Closed System Transfer Devices
Diverse pipeline of transdermal drug products

Growth Outlook

Recent revenue growth from $346,058 to $433,399 in Q1 2026
Strong cash position with $4 million in cash and equivalents
Potential market expansion with innovative drug delivery systems

Financial Highlights

Trailing twelve months revenue of $1.9 million
Current ratio of 5.26 indicates strong liquidity
Net income loss reduced from $3.87 million to $1.24 million in Q1 2026

Nutriband Inc. operates in the biotechnology sector, with a focus on addressing significant healthcare challenges through its innovative products. The company's recent financial performance shows a positive trend in revenue growth, indicating increasing market acceptance of its products. The strong liquidity position suggests that Nutriband is well-equipped to fund its ongoing research and development initiatives. As the company continues to advance its product pipeline, it may capture a larger share of the growing transdermal drug delivery market.

AI Generated • Aug 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Orlando, FL 32801, US

NTRBW Financials

Key Financial Metrics (TTM)

Gross Margin

28.35%

Operating Margin

-452.61%

Net Income Margin

-448.39%

Return on Equity

-112.60%

Return on Capital

-120.12%

Return on Assets

-117.27%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

5.50K

Avg. Volume

2.55K

Financials (TTM)

Gross Profit

$511.13K

Operating Income

-$8.16M

EBITDA

-$7.89M

Operating Cash Flow

-$4.36M

Capital Expenditure

$5.33K

Free Cash Flow

-$4.36M

Cash & ST Invst.

$4.01M

Total Debt

$232.71K

Nutriband Performance Analysis

Nutriband sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-07-31	-6.7%
Q3	2025-10-31	-44.4%
Q4	2026-01-31	15.8%
Q1	2026-04-30	8.2%

Nutriband sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-07-31	-1666.7%
Q3	2025-10-31	84.9%
Q4	2026-01-31	75.1%
Q1	2026-04-30	-25.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$433.40K

-35.1%

Gross Profit

$196.80K

-21.9%

Gross Margin

45.41%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$1.24M

+10.6%

EBITDA

-$1.20M

+9.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$4.01M

+35.2%

Total Debt

$232.71K

-17.6%

Accounts Receivable

$2.63K

-97.2%

Inventory

$121.49K

-43.6%

Long Term Debt

$70.18K

-43.3%

Short Term Debt

$162.54K

+2.4%

Return on Assets

-1.17%

N/A

Return on Invested Capital

-1.35%

N/A

Free Cash Flow

-$563.10K

+57.9%

Operating Cash Flow

-$563.10K

+57.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IBIOiBio, Inc.

IBIOiBio, Inc.$1.26-0.79%

INTSIntensity Therapeutics, Inc.

INTSIntensity Therapeutics, Inc.$4.07-3.33%

ITRMIterum Therapeutics plc

ITRMIterum Therapeutics plc$0.03-10.98%

PLURPluri Inc.

PLURPluri Inc.$1.46-0.68%

CVKDCadrenal Therapeutics, Inc. Common Stock

CVKDCadrenal Therapeutics, Inc. Common Stock$1.51-13.71%

RLYBRallybio Corporation

RLYBRallybio Corporation$16.69-0.60%

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$3.87-3.25%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$14.06+0.06%

NVDANvidia

NVDANvidia$217.44-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.33-0.06%

INTCIntel

INTCIntel$88.97-0.01%

ONDSOndas

ONDSOndas$7.04-0.08%

NUNu Holdings

NUNu Holdings$14.46-0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.38-0.02%

Questions About NTRBW

What is the current price of Nutriband?

Nutriband is trading at $0.35 per share.

What is the 52-week range for Nutriband?

Over the past 52 weeks, Nutriband has traded between $0.25 and $2.99.

How much debt does Nutriband have?

Nutriband total debt is unavailable.

How much cash does Nutriband have on hand?

Nutriband does not have cash on hand data available.

What is Nutriband’s dividend yield?

Nutriband does not currently have a dividend yield.

Nutriband(NASDAQ) NTRBW

Nutriband Financials at a Glance

NTRBW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nutriband

NTRBW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nutriband Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NTRBW

What is the current price of Nutriband?

What is the 52-week range for Nutriband?

How much debt does Nutriband have?

How much cash does Nutriband have on hand?

What is Nutriband’s dividend yield?

Premium Investing Services